Saptarshi Sinha and Chanakya Nath Kundu*
Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha, India
*Corresponding Author: Chanakya Nath Kundu, Professor, Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha, India.
Received: December 29, 2022; Published: March 01, 2023
Breast cancer is regarded as the most common type of malignancy affecting women worldwide. In 2020, it became the most commonly diagnosed cancer, surpassing lung and other types of cancer . Currently, the different breast cancer treatment options include chemotherapy, radiotherapy, and hormone therapy. But the cancer cells have devised ways to bypass the therapeutic effects of these treatment strategies . Moreover, the chemotherapeutic drugs have been found to exhibit certain adverse effects, including high cytotoxicity, off-target effect, development of chemoresistance, and reduced bioavailability . Hence, it is now imperative for the cancer biologists to conduct extensive research and develop novel chemotherapeutic regimens that will minimize the side effects and also effectively kill the breast cancer cells.
Citation: Saptarshi Sinha and Chanakya Nath Kundu. “Red Wine Polyphenol Resveratrol Reduces Breast Cancer Progression and PARP Inhibitor Olaparib Efficiently Enhances its Anti-cancer Action" Acta Scientific Cancer Biology 7.2 (2023): 01-02.
Copyright: © 2022 Saptarshi Sinha and Chanakya Nath Kundu. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.